Atorvastatin intra-subject Variability [Study As­sess­ment]

posted by nobody – 2017-09-27 12:11 (2689 d 22:45 ago) – Posting: # 17832
Views: 5,536

❝ Chance?

Maybe, but...

❝ Better assay?

No

❝ Design differences?

How?

❝ Lesser within-batch variability (-ies) than in the studies you compare to?

Variability has been attributed to various physiological sources, including e.g. liver function, transporter status:

https://www.ncbi.nlm.nih.gov/pubmed/22167570
https://www.ncbi.nlm.nih.gov/pubmed/21548957
https://www.ncbi.nlm.nih.gov/pubmed/20818835

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,664 registered users;
189 visitors (0 registered, 189 guests [including 4 identified bots]).
Forum time: 09:57 CET (Europe/Vienna)

Every system is perfectly designed
to get the results it gets.    Paul B. Batalden

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5